Crystalline cholesterol oil-based suspension (DrugBank: Cholesterol)
6 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
19 | ライソゾーム病 | 0 |
90 | 網膜色素変性症 | 0 |
160 | 先天性魚鱗癬 | 0 |
259 | レシチンコレステロールアシルトランスフェラーゼ欠損症 | 0 |
261 | タンジール病 | 0 |
310 | 先天異常症候群 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00272844 (ClinicalTrials.gov) | January 1998 | 4/1/2006 | Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome | Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome | Smith-Lemli-Opitz Syndrome | Drug: crystalline cholesterol oil-based suspension | Boston Children’s Hospital | NULL | Completed | N/A | N/A | All | 23 | Phase 1;Phase 2 | United States |